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Introduction
Multinucleation and cell hypertrophy are important cellular pro-
cesses that generally arise from the fusion of mononucleated cells, 
giving rise to an enlarged multinucleated cell called a syncytium. 
Syncytia are specialist cells types that play important roles in 
normal physiology and disease including multinucleated giant 
cells that derive from macrophage fusion at the sites of inflam-
mation,1,2 osteoclasts in bone tissue,3 trophoblasts of the placenta4 
and skeletal muscle cells.5 Enlarged multinucleated cells have 
been associated with many different types of cancer6-10—involv-
ing cell-cell fusion events11 or cell-in-cell internalization pro-
cesses.12 Some important disease agents induce multinucleation 
in host cells including viruses such as HIV,13 bacterial pathogens 
such as Mycobacterium tuberculosis14 and lesser known pathogens 
like microsporidia.15 However, despite the involvement of multi-
nucleated cells in a broad range of physiological processes, little 
is known about the underlying molecular mechanisms that lead 
to their formation, although it is believed to be a complex and 
tightly controlled event.16
The human enteric pathogen enteropathogenic E. coli (EPEC) 
delivers over 20 virulence-related proteins, termed effectors, into 
epithelial cells lining the small intestine resulting in severe diar-
rhea.17 Most EPEC effectors have been functionally characterized, 
leading to the prevailing view that effector proteins are highly mul-
tifunctional.18,19 EspF is a relatively small but well-studied EPEC 
effector20 that displays a broad range of biological activities includ-
ing the targeting of host mitochondria21 and nucleoli leading to 
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their dysfunction.22 EspF is a modular protein with several defined 
domains including a mitochondrial targeting sequence in the 
N-terminus, a nucleolar targeting domain directly downstream, 
and a C-terminal polyproline rich repeat (PRR) region.20 This 
latter region has been implicated in membrane remodeling and 
modulation of the cytoskeleton within host cells.23,24
Here, we show that EspF induces overt phenotypical and 
behavioral changes when expressed ectopically within human 
small intestinal cells. We show that EspF-induced multinucle-
ation and cell hypertrophy occur concomitantly with cell-in-cell 
fusion events as we observed a marked induction in this process. 
EspF variants revealed that the observed cellular phenotypes 
were dependent on the C-terminal proline-rich repeat region. 
Taken together, this study identifies a single bacterial protein that 
induces extreme alterations in epithelial cell behavior leading to 
the induction of a multinucleated syncytium-like intestinal cell.
Results and Discussion
EspF targets the mitochondrion, nucleolus and cytoplasm of 
a range of human host cells.21,22,28 Its predominant target site 
is the mitochondrion, thus removal or mutation (L16E) of the 
N-terminal mitochondrial targeting sequence of EspF enables a 
better assessment of its cytoplasmic and nucleolar functions.22,28 
Our previous work on EspF, looked at the effects of a variant of 
EspF (L16E)-tagged EGFP expressed within the small intesti-
nal cell line TC-7—a clonal line of the more commonly used 
Caco-2 model. TC-7 cells provide a homogeneous population 
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Figure 1. Expression of EspF(L16E)-GFP in small intestinal cells induces extreme cell hypertrophy and multinucleation. TC-7 intestinal cells were trans-
fected in suspension and seeded at high density. Cells were then visualized on different days post infection as described in Materials and Methods.
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EspF targets host organelles and also exhibits several cyto-
plasmic functions.20 The EspF protein has a modular architec-
ture (Fig. 4) and can be broadly divided into 3 sub-domains 
that include the mitochondrial localization sequence, nucleolar 
targeting domain and a C-terminal proline rich repeat (PRR; 
Fig. 4A). As the L16E version of EspF was used throughout this 
study, the targeting of mitochondria by EspF was not responsible 
of enterocytes that enables a better assessment of phenotypes 
and cell behavior, particularly of individual cells. A transfec-
tion protocol was developed for TC-7 cells in which monolayers 
expressing a protein of interest were ~100% confluent on day 1 
post-transfection (see Materials and Methods). Microscopy anal-
ysis of TC-7 cells expressing EspF(L16E)-EGFP (herein termed 
EspF-GFP) revealed the protein targeted the cytoplasm and 
nucleolus (Fig. 1A) as described previously.22 However, we also 
noticed that cells expressing EspF-GFP at much lower levels (see 
Materials and Methods) exhibited a marked increase in the num-
ber of nuclei and cell size, unlike those expressing higher levels of 
EspF above the threshold level (that were detected as described 
in Materials and Methods section). Thus, a time course experi-
ment was performed to investigate the linkage between low EspF 
expression and these phenotypes.
TC-7 cells expressing EspF-GFP on day 1 post-transfection 
remained mononuclear (unless dividing), similar to adjacent 
untransfected cells in the same well (Figs. 1A and 2A). Cells 
expressing EspF-GFP exhibited a progressive increase in cell 
hypertrophy (maximal diameter) and multinucleation (counted 
as three or more nuclei) from day 2 to day 6 post-transfection 
(Figs. 1A–F and 2). Untransfected cells or cells expressing EGFP 
alone (not shown) were unchanged—with a slight decrease in cell 
diameter/nuclear size due to increases in cell confluency (Figs. 1 
and 2). Indeed, comparing day 1 with day 5 post-transfection 
revealed that the EspF-induced multinucleated cells, had a ~22-
fold mean increase in cell size (Fig. 2C) and a 14-fold mean 
increase in nuclei (Fig. 2A) with some cells displaying ~50 nuclei 
per cell. As the doubling time of TC-7 cells is approximately 
26 h,29 this data suggested that multinucleation in cells that con-
tained 40–50 nuclei was unlinked to the cell cycle but may have 
arose by another mechanism. Taken together, the data shows that 
ectopic expression of the cytoplasmic variant of EspF induces 
multinucleation and cell hypertrophy in an epithelial model.
A striking feature of the EspF-expressing TC-7 cells was the 
high levels of internalization of adjacent non-transfected cell 
types (Figs. 1B–F and 3). Confocal sectioning of cells along 
the x-z axis revealed complete internalization of engulfed cells 
(bound by an actin peripheral signal) within the EspF-expressing 
cells (Fig. 3A), using the phalloidin signal to discern cell periph-
ery. Intact internalized cells were negative for EspF-GFP in their 
cytoplasm and nucleus, revealing they were not daughter cells 
of the EspF-expressing cell but were indeed from a neighboring 
cell location. Moreover, all EspF-expressing multinucleated cells 
possessed long cytoplasmic extensions that penetrated between 
the cell-cell interfaces of adjacent epithelial cells (Fig. 3B). These 
extensions in EspF-expressing cells were consistent throughout 
the monolayer reaching lengths of over 50 μm (Fig. 1F) and pro-
vided an explanation for how the smaller cell types were being 
internalized. Quantification of cells on day 4 post-transfection 
revealed that ~90% ± 4.65 (mean ± SD) of EspF-expressing cells 
were in the process of engulfing or had engulfed two or more 
non-transfected cells (Fig. 3C), whereas non-transfected cells 
displayed near-zero levels of internalization (Fig. 3C). Thus, it is 
evident that expression of EspF-GFP within this small intestinal 
model induces extensive cell-in-cell internalization events.
Figure 2. Quantification of phenotypical changes in TC-7 cells induced 
by EspF. TC-7 cells expressing EspF(L16E)-GFP were assessed for (A) nu-
clei number, (B) maximal cell diameter and (C) cell area. Data shows 
mean ± SD; n = 3 with 8 fields of view per experiment. *p value on day 2 
relates to a comparison of transfected and untransfected cells.
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for the phenotypes described. Deletion analysis of EspF 
ruled out a role for nucleolar targeting in multinucleation 
(Fig. 4C; p = 0.95) and cell hypertrophy (Fig. 4B; p = 
0.676) but revealed an essential role for the C-terminal 
PRR domain (Fig. 4B and C; p = 0.01). Indeed, the EspF 
variant Δ21-74, which possesses the intact C-terminal 
PRR half of the protein, was similar to the full length 
EspF in inducing multinucleation and hypertrophy. 
While the first 21 amino acids of EspF were also encoded 
by this variant, they are also encoded by EspF Δ101-184, 
which was defective in inducing the phenotypes. The 
first 21 amino acids are also known to be required for 
bacterial secretion and mitochondrial targeting (Holmes 
et al., 2010), the latter of which was ruled out because 
of the L16E mutation. While we cannot rule out a con-
tributory role for the N-terminal domain, the data dem-
onstrates an essential role for the C-terminal PRR region 
for inducing the phenotypes described. Intriguingly, the 
PRR region of this effector protein has been linked with 
membrane remodeling and cytoskeletal rearrangements, 
both of which are presumably essential for the cell-cell 
internalization events described here. Myoblast fusion, 
which gives rise to skeletal muscle cell syncytia, has been 
shown to depend on N-WASP, a protein that binds EspF 
via its C-terminal PRR domain.30 It seems likely that 
EspF acts through N-WASP to elicit cell fusion events 
and future studies will elucidate whether this is the case. 
Finally, studies with the effector EspF(U)-EGFP, which 
possesses a homologous PRR region to EspF (Alto et al., 
2007), including a variant of the N-WASP binding site, 
showed no induction of multinucleation or cell-cell fusion 
when expressed in TC-7 cells (Fig. 4B and C) although 
EspF(U)-EGFP was notably more toxic than EspF-EGFP 
in TC-7 cells. As EspF(U), contains a variation of the 
N-WASP binding site, this may also explain these dif-
ferences. Alternatively, EspF may encode an unknown 
protein-protein interaction site in its C-terminal repeat 
region that could be mediating the cell fusion events.
In this study, the clonal cell line TC-7 was used for the 
purpose of removing heterogeneity in epithelial popula-
tions, thus it is very unlikely that the multinucleated cells 
were a subset within the TC-7 population. No enlarge-
ment or increases in nucleation were found in untrans-
fected control cells during the time course experiment, 
thus these phenotypes were directly linked to ectopic 
EspF expression. Multinucleation and cell hypertrophy 
in response to EPEC infection has not been previously 
reported although this is very difficult to determine in 
vivo. Thus, it is unclear whether or not EspF possesses 
such functions during the infection process or whether 
they are being suppressed due to the concerted actions 
of other EPEC effector proteins. Furthermore, whether 
these cell types exist within the gastrointestinal tract is 
unknown although this study shows that multinucleation 
in epithelial cells can clearly be induced. Interestingly, 
enlarged multinucleated cells have been reported in 
Figure 3. EspF expression induces cell internalization in an epithelial monolayer. 
(A) TC-7 cells expressing EspF(L16E)-GFP were visualized by confocal microscopy 
and sectioned along the x-z axis. (B) Cytoplasmic extensions (yellow arrow) in 
EspF-expressing cells (day 4 post transfection) were consistently found sur-
rounding non-transfected cell types. (C) Quantification of cell engulfment in 
which only cells engulfing two or more cells were included in the analysis. Data 
shows mean ± SD, n = 3.
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hyperplastic polyps in several epi-
thelial tissue types suggesting that 
they can, under certain conditions, 
display these extreme phenotypes.31 
Nonetheless, multinucleation, cell 
enlargement and cell-cell internal-
ization are consistent features of 
infectious diseases, cancers, inflam-
mation and normal physiological 
processes, yet we know little of the 
molecular events unpinning them. 
The documented examples that 
N-WASP is essential for cell-cell 
fusion events29 suggests the enticing 
possibility that EspF is functioning 
through N-WASP via its N-WASP 
binding site to induce cell fusion. As 
bacterial effector proteins commonly 
mimic vertebrate host proteins, it 
seems plausible that the EspF PRR 
may have counterparts in higher 
eukaryotes to regulate the cellular 
responses described in this study.
Materials and Methods
Plasmids. The plasmids used in this 
study were derived from pEGFP-
N1 (Clontech) and encode mutated 
variants of EspF fused to EGFP as 
described previously.22 The source 
of EspF was the enteropathogenic 
E. coli strain E2348/69. Plasmids 
were purified to ~2 mg/mL using the 
Qiagen midiprep kit according to the 
manufacturer’s instructions.
Small intestinal model system. The Caco-2 clonal cell line 
TC-7 is a homogeneous small intestinal model that has been well 
characterized since its isolation.25 TC-7 cells were maintained in 
tissue culture flasks at 37°C as described previously.26 Routinely, 
the cells were fed fresh Dulbecco’s minimal Eagle’s medium 
(DMEM; Invitrogen) supplemented with 1× penicillin/strepto-
mycin and 10% (v/v) heat inactivated fetal calf serum (Gibco).
Transfection of TC-7 cells with pEGFP-N1-EspF vari-
ants. Following trypsinization, TC-7 cells were diluted in fresh 
DMEM (without supplements) to a concentration of 2 × 106 
cells/mL. Lipofectamine 2000 (Invitrogen) was mixed with 
plasmid DNA according to the manufacturer’s instructions and 
added to the cell suspension. Cells were then rotated at 37°C for 
30 min and then transferred to 24-well plates (Corning) and cen-
trifuged at 500 g for 5 min onto 13 mm sterile glass coverslips. 
Cells were left for 6h at 37°C and the medium was replaced with 
fresh complete DMEM. By 24 h post-transfection, the cells had 
attached to the glass coverslip and were confluent.
Staining of transfected cells and confocal microscopy. 
Transfected TC-7 were fixed in 4% (w/v) para-formaldehyde in 
Figure 4. The proline rich repeat region in EspF is responsible for multinucleation and cell hypertrophy. 
(A) The modular architecture of EspF is shown in top schematic with the different constructs used in 
this study shown beneath. Constructs have an L16E substitution, or have been deleted for the nucleolar 
localization sequence (noLS) or the proline rich repeat (Prr). EspF(u) is an effector that contains a ho-
mologous Prr to EspF. Maximal cell diameter (B) and levels of multinucleation [three or more nuclei; (C)] 
were measured in cells expressing the different constructs (day 4 post-transfection). Data shows mean 
± SD, n = 3.
PBS for 15 min, permeabilized for 5 min with 0.2% (w/w) Triton 
X-100 and stained as described.27 Briefly, fixed cells were stained 
with TRITC-labeled phalloidin (Invitrogen) to stain filamen-
tous actin and DAPI to stain cell nuclei. Cells were mounted in 
Mowiol containing p-phenylenediamine and visualized on a Leica 
SP2 confocal microscope with a 63× objective lens. Maximal cell 
diameter and cell area were determined using phallodin stain-
ing to indicate cell periphery and measured using Leica confocal 
software, typically from 8 randomly selected fields of view per 
experiment at 63× magnification. Cells exhibiting low EspF-GFP 
expression were visualized by empirically increasing the optical 
gain of the confocal microscope, while cells expressing much 
higher levels of EspF-GFP (above maximal saturation intensity 
at this optical gain) were not included in this study as they have 
been described elsewhere.22
Statistical analysis. All experiments were repeated three 
times, unless otherwise stated. Data are expressed as mean ± SD 
and was analyzed by the Student’s t-test using the statistical soft-
ware package SPSS.
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